![](https://sourceonhealth.wpenginepowered.com/wp-content/uploads/2019/04/SLIHCQ-title-1.png)
HB 756 – Maryland
Status: Inactive / DeadYear Introduced: 2020
Link: http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0756?ys=2020RS
Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers – Reimbursement Requirements. Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for drug products for which there is a certain generic equivalent; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus the fee-for-service professional dispensing fee determined by the Maryland Department of Health in accordance with the most recent in-State cost-of-dispensing survey; etc.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found